This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Commission of the European Communities. 1987. Guidelines on the production and quality control of medicinal products de rived by recombinant DNA technology. Tibtech 5: G1.
Commission of the European Communities. 1988. Guidelines on the production and quality control of monoclonal antibodies of murine origin intended for use in man. Tibtech 6: G5.
Department of Health and Human Services of the FDA, Office of Biologies Research and Review. 1987. Points to consider in the manufacture and testing of monoclonal antibody products for human use.
Kearns, M.J. 1989. Containment of biologi cal hazards: effect of guidelines on the de sign of pharmaceutical facilities and process equipment. Pharmaceut. Eng. 9(4): 17.
Comer, M.J., Kearns, M.J., Wahl, J., Mun-ster, M., Lorenz, T., Szperalski, B., Koch, S., Behrendt, U. and Brunner, H. Industrial production of monoclonal antibodies and therapeutic proteins by dialysis fermentation. Cytotechnology, in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kearns, M. Integrated Design for Mammalian Cell Culture. Nat Biotechnol 8, 409–413 (1990). https://doi.org/10.1038/nbt0590-409
Issue Date:
DOI: https://doi.org/10.1038/nbt0590-409